Invention Grant
- Patent Title: Omega 3 fatty acids, no releasing compound and vitamin B12 as neuroprotectant in patients with no dementia
-
Application No.: US16336308Application Date: 2017-09-29
-
Publication No.: US10821130B2Publication Date: 2020-11-03
- Inventor: Yvonne Beata Silber , Jeroen Antonius Johannes Schmitt , Corina Boschat , Julie Hudry-Labbe , Claus Rieker
- Applicant: NESTEC S.A.
- Applicant Address: CH Vevey
- Assignee: Societe des Produits Nestle S.A.
- Current Assignee: Societe des Produits Nestle S.A.
- Current Assignee Address: CH Vevey
- Agency: K&L Gates LLP
- International Application: PCT/EP2017/074729 WO 20170929
- International Announcement: WO2018/060395 WO 20180405
- Main IPC: A61K31/714
- IPC: A61K31/714 ; A61K31/202 ; A61K31/4415 ; A61K31/519 ; A61K31/198 ; A61P43/00 ; A61P25/28 ; A61K31/14 ; A61K31/17 ; A61K31/375 ; A61K31/4406 ; A61K33/00 ; A61K31/197 ; A61K31/341 ; A61K31/355 ; A61K31/4188 ; A61K31/455 ; A61K31/51 ; A61K31/525 ; A61K31/59 ; A61K31/675 ; A61K33/04

Abstract:
A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid, a nitric oxide releasing compound, and Vitamin B12. The composition is administered in a daily dose that provides 50 to 500 times the recommended daily requirement (RDA) of Vitamin B12 per day, for example about 200 times the RDA of Vitamin B12 per day. Optionally Vitamin B6 and/or Vitamin B9 can be included in the composition. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-β phagocytosis, or decreasing or maintaining neuroinflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human.
Public/Granted literature
Information query